January 2017 FDA Recall Docetaxel by Dr. Reddy's Laboratories, Inc.
D-0213-2018 - Defective Container

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on January 9, 2017 for the product Docetaxel. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0213-2018

Reason for Recall
Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.
Initiated
01-09-2017
Reported
01-17-2018
Quantity
1,051 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Distributed nationwide in the USA, Uzbekistan, and Myanmar
Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11

Batch or Lot Expiration Information

Lot# : H7044, Exp 05/19

Affected Packages Involved in this Recall